These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 10639596)
1. Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh. Wall NR; Mohammad RM; Reddy KB; Al-Katib AM Int J Mol Med; 2000 Feb; 5(2):165-71. PubMed ID: 10639596 [TBL] [Abstract][Full Text] [Related]
2. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh. Wall NR; Mohammad RM; Nabha SM; Pettit GR; Al-Katib AM Biochem Biophys Res Commun; 1999 Dec; 266(1):76-80. PubMed ID: 10581168 [TBL] [Abstract][Full Text] [Related]
3. Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh. Wall NR; Mohammad RM; Al-Katib AM Leuk Res; 1999 Oct; 23(10):881-8. PubMed ID: 10573132 [TBL] [Abstract][Full Text] [Related]
4. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis. Chen C; Lin H; Karanes C; Pettit GR; Chen BD Cancer Res; 2000 Aug; 60(16):4377-85. PubMed ID: 10969781 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells. Zhang XM; Lin H; Chen C; Chen BD Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitination of protein kinase C-alpha and degradation by the proteasome. Lee HW; Smith L; Pettit GR; Vinitsky A; Smith JB J Biol Chem; 1996 Aug; 271(35):20973-6. PubMed ID: 8702857 [TBL] [Abstract][Full Text] [Related]
7. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Maki CG; Huibregtse JM; Howley PM Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711 [TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh. Wall NR; Mohammad RM; Al-Katib AM Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2. Mohammad RM; Beck FW; Katato K; Hamdy N; Wall N; Al-Katib A Biol Chem; 1998 Oct; 379(10):1253-61. PubMed ID: 9820586 [TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line. Song X; Sheppard HM; Norman AW; Liu X J Biol Chem; 1999 Jan; 274(3):1677-82. PubMed ID: 9880547 [TBL] [Abstract][Full Text] [Related]
11. Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells. Fukuchi K; Maruyama H; Takagi Y; Gomi K Biochim Biophys Acta; 1999 Aug; 1451(1):206-10. PubMed ID: 10446402 [TBL] [Abstract][Full Text] [Related]
12. Demonstration that a human 26S proteolytic complex consists of a proteasome and multiple associated protein components and hydrolyzes ATP and ubiquitin-ligated proteins by closely linked mechanisms. Kanayama HO; Tamura T; Ugai S; Kagawa S; Tanahashi N; Yoshimura T; Tanaka K; Ichihara A Eur J Biochem; 1992 Jun; 206(2):567-78. PubMed ID: 1317798 [TBL] [Abstract][Full Text] [Related]
13. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells. Thomas A; Pepper C; Hoy T; Bentley P Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360 [TBL] [Abstract][Full Text] [Related]
14. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha. Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294 [TBL] [Abstract][Full Text] [Related]
15. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Li B; Dou QP Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3850-5. PubMed ID: 10725400 [TBL] [Abstract][Full Text] [Related]
16. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh. al-Katib A; Mohammad RM; Khan K; Dan ME; Pettit GR; Sensenbrenner LL J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068 [TBL] [Abstract][Full Text] [Related]
17. Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway. Mezey E; Rennie-Tankersley L; Potter JJ Biochem Biophys Res Commun; 2001 Jul; 285(3):644-8. PubMed ID: 11453641 [TBL] [Abstract][Full Text] [Related]
18. Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L). Wang Z; Wang S; Dai Y; Grant S J Pharmacol Exp Ther; 2002 May; 301(2):568-77. PubMed ID: 11961058 [TBL] [Abstract][Full Text] [Related]
19. Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism. De Lorenzo MS; Yamaguchi K; Subbaramaiah K; Dannenberg AJ Clin Cancer Res; 2003 Oct; 9(13):5036-43. PubMed ID: 14581379 [TBL] [Abstract][Full Text] [Related]
20. Identification of two distinct pathways of protein kinase Calpha down-regulation in intestinal epithelial cells. Leontieva OV; Black JD J Biol Chem; 2004 Feb; 279(7):5788-801. PubMed ID: 14638691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]